Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Enhabit, Inc (EHAB)
NYSE:EHAB
Holding EHAB?
Track your performance easily
EHAB Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$6.85 - $11.74
Previous Close$8.01
Volume138.09K
Average Volume (3M)624.99K
Market Cap
$379.65M
Enterprise Value$964.88M
Total Cash (Recent Filing)$45.70M
Total Debt (Recent Filing)$581.00M
Price to Earnings (P/E)―
Beta0.61
Next Earnings
Feb 12, 2025EPS Estimate
$0.07Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.32
Shares Outstanding50,283,308
10 Day Avg. Volume436,433
30 Day Avg. Volume624,994
Standard Deviation0.17
R-Squared0.15
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)0.60
Price to Sales (P/S)0.38
Price to Cash Flow (P/CF)10.30
P/FCF Ratio11.10
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.93
Enterprise Value/Gross Profit1.89
Enterprise Value/Ebitda-20.36
Forecast
1Y Price Target
$8.00Price Target Upside5.96% Upside
Rating ConsensusHold
Number of Analyst Covering2
Enhabit, Inc News
PremiumCompany Announcements
Enhabit, Inc. Reports Q3 2024 Financial Performance
PremiumCompany Announcements
Enhabit, Inc. Appoints New CFO for Strategic Growth
PremiumCompany Announcements
Enhabit, Inc Reports Mixed Q3 2024 Financial Results
PremiumCompany Announcements
Enhabit, Inc. Welcomes New Chief Accounting OfficerBulls Say, Bears Say
Bulls Say
EBITDA GrowthHospice results generally look good with 30% EBITDA growth, solid ADC improvement, and stable costs per patient day.
Financial PerformanceHospice EBITDA increased 30% year-over-year with an improvement in margin to 19%.
Revenue GrowthEHAB expects Hospice revenue to grow by mid-to-high single digits based on a +4% increase to reimbursement rates and volume increases through investment in case management models and business development teams.
Bears Say
Financial PerformanceThe company's financial performance is under pressure as Home Health EBITDA missed expectations by 12%, signaling potential challenges in meeting financial targets.
Investor ConcernsInvestors are cautious about the company's ability to recruit and retain clinicians, as well as control general and administrative costs, contributing to a perception of the company as a 'show-me' story requiring proof of consistent performance.
Strategic DecisionsThe decision to remain public after a strategic review has eliminated potential acquisition opportunities, causing investor concerns over the lack of strategic interest at a favorable price.
---
Ownership Overview
2.23% Insiders
15.87% Mutual Funds
4.23% Other Institutional Investors
63.73% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
EHAB FAQ
What was Enhabit, Inc’s price range in the past 12 months?
Enhabit, Inc lowest stock price was $6.85 and its highest was $11.74 in the past 12 months.
What is Enhabit, Inc’s market cap?
Currently, no data Available
When is Enhabit, Inc’s upcoming earnings report date?
Enhabit, Inc’s upcoming earnings report date is Feb 12, 2025 which is in 92 days.
How were Enhabit, Inc’s earnings last quarter?
Enhabit, Inc released its earnings results on Nov 06, 2024. The company reported $0.03 earnings per share for the quarter, missing the consensus estimate of $0.039 by -$0.009.
Is Enhabit, Inc overvalued?
According to Wall Street analysts Enhabit, Inc’s price is currently Undervalued.
Does Enhabit, Inc pay dividends?
Enhabit, Inc does not currently pay dividends.
What is Enhabit, Inc’s EPS estimate?
Enhabit, Inc’s EPS estimate is $0.07.
How many shares outstanding does Enhabit, Inc have?
Enhabit, Inc has 50,284,120 shares outstanding.
What happened to Enhabit, Inc’s price movement after its last earnings report?
Enhabit, Inc reported an EPS of $0.03 in its last earnings report, missing expectations of $0.039. Following the earnings report the stock price went up 0.126%.
Which hedge fund is a major shareholder of Enhabit, Inc?
Among the largest hedge funds holding Enhabit, Inc’s share is Deerfield Management Company, LP. It holds Enhabit, Inc’s shares valued at 45M.
---
Enhabit, Inc Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$8.00 (5.96% Upside)
$8.00 (5.96% Upside)
Hedge Fund Trend
Decreased
By 776.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $98.7K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-13.87%
12-Months-Change
Fundamentals
Return on Equity
-18.77%
Trailing 12-Months
Asset Growth
-10.10%
Trailing 12-Months
Company Description
Enhabit, Inc
Enhabit Inc provides home health and hospice services in the United States. It offers care where patients prefer it: in their homes. It operates business in two segments: home health and hospice. Its home health agencies provide a comprehensive range of Medicare-certified skilled home health services, including skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services.
---
EHAB Company Deck
---
EHAB Earnings Call
Q3 2024
0:00 / 0:00
---
EHAB Stock 12 Month Forecast
Average Price Target
$8.00
▲(5.96% Upside)
Technical Analysis
Best Analysts Covering EHAB
1 Year
1 Year Success Rate
6/6 ratings generated profit
1 Year Average Return
+16.47%
reiterated a sell rating 3 months ago
Copying Joanna Gajuk's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +16.47% per trade.
---